NBDC Research ID: hum0225.v1

 

SUMMARY

Aims: Estimating the risks of developing adult T-cell leukemia (ATL) through a genetic analysis of human T-cell leukemia virus (HTLV-1)-associated myelopathy (HAM)

Methods: Target capture sequencing by using of NGS technology

Participants/Materials: HAM 21 cases (infected and uninfected cells)

 

Dataset IDType of DataCriteriaRelease Date
JGAS000226 NGS (Target Capture) Controlled-access (Type I) 2020/05/08

*Release Note

* Data users need to apply an application for Using NBDC Human Data to reach the Controlled-access Data. Learn more

 

MOLECULAR DATA

JGAS000226

Participants/Materials

HAM(ICD-10:A858/B973): 21 cases (46 samples)

    infected cells (tumor cells): 23 samples (including post-ATL specimens for 2 cases)

    uninfected cells (non-tumor cells): 23 samples (including post-ATL specimens for 2 cases)

Targets Target Capture
Target Loci for Capture Methods 280 genes (human) including 50 candidate genes for ATL and whole genome of HTLV-1 provirus
Platform Illumina [HiSeq 2500/3000]
Library Source DNAs extracted from PBMC (infected and uninfected cells) of HAM patients
Cell Lines -
Library Construction (kit name) SureSelect XT HS Target Enrichment System
Fragmentation Methods Ultrasonic fragmentation (Covaris)
Spot Type Paired-end
Read Length (without Barcodes, Adaptors, Primers, and Linkers) 100 bp
Japanese Genotype-phenotype Archive Dataset ID JGAD000318
Total Data Volume 238 GB (fastq)
Comments (Policies) NBDC policy

 

DATA PROVIDER

Principal Investigator: Makoto Yamagishi / Yoshihisa Yamano

Affiliation: Graduate School of Frontier Sciences, The University of Tokyo / Institute of Medical Science, St. Marianna University School of Medicine

Project / Group Name: Laboratory of Tumor Cell Biology / Department of Rare Disases Research

Funds / Grants (Research Project Number):

NameTitleProject Number
Research Program on Emerging and Re-emerging Infectious Diseases, Japan Agency for Medical Research and Development (AMED) Development of risk stratification and prevention for HTLV-1-associated diseases based on multi-omics database JP20fk0108126
KAKENHI Grant-in-Aid for Scientific Research (B) Analysis of genome/epigenome control mechanism that regulates abnormal traits of HTLV-1 infected cells in HAM 19H03575
Practical Research Project for Rare / Intractable Diseases, Japan Agency for Medical Research and Development (AMED) The establishment of evidence for clinical guideline development on HAM and HTLV-1-related refractory disease through integration of patient registry JP19ek0109356

 

PUBLICATIONS

TitleDOIDataset ID
1 Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis doi: 10.1073/pnas.1920346117 JGAD000318
2

 

USRES (Controlled-access Data)

Principal InvestigatorAffiliationCountry/RegionResearch TitleData in Use (Dataset ID)Period of Data Use
Masao Matsuoka Kumamoto University School of Medicine Hematology, Rheumatology and Infectious Diseases Japan Retrospective observational study of characteristics, clinical course and treatment of malignant lymphoma and adult T-cell leukemia/lymphoma with genetic and pathological evaluations JGAD000318 2022/05/16-2030/03/31